1. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared 
Gilles Wandeler, Lloyd Mulenga, Michael J. Vinikoor, Helen Kovari, Manuel Battegay, Alexandra Calmy, Matthias Cavassini, Enos Bernasconi, Patrick Schmid, Carolyn Bolton-Moore, Edford Sinkala, Benjamin H. Chi, Matthias Egger, Andri Rauch 
International Journal of Infectious Diseases 
Volume 51, Pages (October 2016)
DOI: /j.ijid
Copyright © 2016 The Author(s) Terms and Conditions

2. Figure 1
Proportion of patients with significant fibrosis (A) and cirrhosis (B), by country and HBV status.
International Journal of Infectious Diseases  , DOI: ( /j.ijid )
Copyright © 2016 The Author(s) Terms and Conditions

3. Figure 2
Risk factors for significant liver fibrosis (APRI ≥1.5) from multivariable logistic regression, by cohort.
International Journal of Infectious Diseases  , DOI: ( /j.ijid )
Copyright © 2016 The Author(s) Terms and Conditions

4. Figure 3
Proportion of patients with significant fibrosis, by country and HBV replication status.
International Journal of Infectious Diseases  , DOI: ( /j.ijid )
Copyright © 2016 The Author(s) Terms and Conditions